요약정보
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.
- Resource Type
- Academic Journal
- Authors
- Zhao M; Department of Minimally Invasive Interventional Therapy, Liver Cancer Study and Service Group, Sun Yat-Sen University Cancer Center, Guangzhou, China. drmingzhao@outlook.com.; State Key Laboratory of Oncology in South China, 651 Dongfeng East Road, Guangzhou, 510060, Guangdong, China. drmingzhao@outlook.com.; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng East Road, Guangzhou, 510060, Guangdong, China. drmingzhao@outlook.com.; Guo Z; Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.; Zou YH; Department of Interventional and Vascular Surgery, Peking University First Hospital, Beijing, China.; Li X; Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Yan ZP; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Chen MS; Department of Liver Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Fan WJ; Department of Minimally Invasive Interventional Therapy, Liver Cancer Study and Service Group, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Li HL; Department of Radiology, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Yang JJ; Department of Interventional Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China.; Chen XM; Department of Interventional Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Xu LF; Department of Interventional Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.; Zhang YW; Hepatopancreatbiliary Center, Tsinghua University Affiliated Beijing Tsinghua Changgung Hospital, Beijing, China.; Zhu KS; Department of Minimally Invasive Interventional Radiology and Department of Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Sun JH; Division of Hepatobiliary and Pancreatic Surgery, Hepatobiliary and Pancreatic Interventional Treatment Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Li JP; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Jin Y; The Interventional Therapy Department, The Second Affiliated Hospital of Soochow University, Suzhou, China.; Yu HP; Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.; Duan F; Department of Interventional Radiology, The General Hospital of Chinese People's Liberation Army, Beijing, China.; Xiong B; Department of Interventional Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Yin GW; Department of Interventional Radiology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.; Lin HL; Department of Interventional Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.; Ma YL; Department of Interventional Therapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Wang HM; Department of Interventional Therapy, The Fifth Medical Center of the Chinese PLA General Hospital, Beijing, China.; Gu SZ; Department of Interventional Therapy, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; Si TG; Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.; Wang XD; Departments of Interventional Oncology, Peking University Cancer Hospital and Institute, Beijing, China.; Zhao C; Department of Interventional Therapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.; Yu WC; Department of Interventional Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.; Guo JH; Departments of Interventional Oncology, Peking University Cancer Hospital and Institute, Beijing, China.; Zhai J; Department of Interventional Radiology, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.; Huang YH; Department of Interventional Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Wang WY; Department of Interventional Oncology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Lin HF; Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.; Gu YK; Department of Minimally Invasive Interventional Therapy, Liver Cancer Study and Service Group, Sun Yat-Sen University Cancer Center, Guangzhou, China.; Chen JZ; Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Wang JP; Department of Oncology, First People's Hospital of Foshan, Foshan Hospital of Sun Yat-Sen University, Foshan, China.; Zhang YM; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.; Yi JZ; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.; Lyu N; Department of Minimally Invasive Interventional Therapy, Liver Cancer Study and Service Group, Sun Yat-Sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, 651 Dongfeng East Road, Guangzhou, 510060, Guangdong, China.; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng East Road, Guangzhou, 510060, Guangdong, China.
- Source
- Publisher:
Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN:19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE - Subject
- Language
- English